This paper is in the following e-collection/theme issue:

Mobile Health (mhealth) (2941) Text-messaging (SMS, WeChat etc)-Based Interventions (650)

Published on in Vol 15, No 4 (2013): April

Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study

Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study

Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study

Authors of this article:

Sophie Baron1 ;   Flavie Goutard1, 2 ;   Kunthy Nguon1 ;   Arnaud Tarantola1
Article Authors Cited by (30) Tweetations (16) Metrics

Journals

  1. Vergeire-Dalmacion G, Castillo-Carandang N, Juban N, Amarillo M, Tagle M, Baja E. Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study. JMIR Public Health and Surveillance 2015;1(2):e12 View
  2. Goel S, Bhatnagar N, Sharma D, Singh A. Bridging the Human Resource Gap in Primary Health Care Delivery Systems of Developing Countries With mHealth: Narrative Literature Review. JMIR mhealth and uhealth 2013;1(2):e25 View
  3. Caillet C, Sichanh C, Syhakhang L, Delpierre C, Manithip C, Mayxay M, Lapeyre-Mestre M, Newton P, Roussin A. Population awareness of risks related to medicinal product use in Vientiane Capital, Lao PDR: a cross-sectional study for public health improvement in low and middle income countries. BMC Public Health 2015;15(1) View
  4. Kim S, Patel M, Hinman A. Use of m-Health in polio eradication and other immunization activities in developing countries. Vaccine 2017;35(10):1373 View
  5. Ribeiro-Vaz I, Silva A, Costa Santos C, Cruz-Correia R. How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis. BMC Medical Informatics and Decision Making 2016;16(1) View
  6. Diallo M, Diallo A, Dicko A, Richard V, Espié E. Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors. BMC Infectious Diseases 2019;19(1) View
  7. Berrewaerts J, Delbecque L, Orban P, Desseilles M. Patient Participation and the Use of Ehealth Tools for Pharmacoviligance. Frontiers in Pharmacology 2016;7 View
  8. Menezes N, Wali S, Ganachari M. Pharmacist-led intervention on adverse events following immunization at a tertiary care hospital: A randomized controlled study. Indian Journal of Health Sciences and Biomedical Research (KLEU) 2020;13(2):127 View
  9. Leeb A, Regan A, Peters I, Leeb C, Leeb G, Effler P. Using automated text messages to monitor adverse events following immunisation in general practice. Medical Journal of Australia 2014;200(7):416 View
  10. Iribarren S, Brown W, Giguere R, Stone P, Schnall R, Staggers N, Carballo-Diéguez A. Scoping review and evaluation of SMS/text messaging platforms for mHealth projects or clinical interventions. International Journal of Medical Informatics 2017;101:28 View
  11. Ateudjieu J, Stoll B, Nguefack-Tsague G, Tchangou C, Genton B. Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): A randomized controlled trial. Vaccine 2014;32(43):5662 View
  12. Tozzi A, Gesualdo F, D’Ambrosio A, Pandolfi E, Agricola E, Lopalco P. Can Digital Tools Be Used for Improving Immunization Programs?. Frontiers in Public Health 2016;4 View
  13. Clothier H, Selvaraj G, Easton M, Lewis G, Crawford N, Buttery J. Consumer reporting of adverse events following immunization. Human Vaccines & Immunotherapeutics 2014;10(12):3726 View
  14. Brody C, Tuot S, Chhoun P, Swendenman D, Kaplan K, Yi S. Mobile Link – a theory-based messaging intervention for improving sexual and reproductive health of female entertainment workers in Cambodia: study protocol of a randomized controlled trial. Trials 2018;19(1) View
  15. Goutard F, Binot A, Duboz R, Rasamoelina-Andriamanivo H, Pedrono M, Holl D, Peyre M, Cappelle J, Chevalier V, Figuié M, Molia S, Roger F. How to reach the poor? Surveillance in low-income countries, lessons from experiences in Cambodia and Madagascar. Preventive Veterinary Medicine 2015;120(1):12 View
  16. Wilson K, Atkinson K, Westeinde J, Bell C, Marty K, Fergusson D, Deeks S, Crowcroft N, Bettinger J. An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination. Human Vaccines & Immunotherapeutics 2016:1 View
  17. Regan A, Blyth C, Tracey L, Mak D, Richmond P, Effler P. Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation. Vaccine 2015;33(31):3689 View
  18. Agoro O, Kibira S, Freeman J, Fraser H. Barriers to the success of an electronic pharmacovigilance reporting system in Kenya: an evaluation three years post implementation. Journal of the American Medical Informatics Association 2018;25(6):627 View
  19. Gold M, Lincoln G, Bednarz J, Braunack-Mayer A, Stocks N. Consumer acceptability and validity of m-Health for the detection of adverse events following immunization – The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial. Vaccine 2021;39(2):237 View
  20. Brody C, Dhaliwal S, Tuot S, Johnson M, Pal K, Yi S. Are Text Messages a Feasible and Acceptable Way to Reach Female Entertainment Workers in Cambodia with Health Messages? A Cross-Sectional Phone Survey. JMIR mHealth and uHealth 2016;4(2):e52 View
  21. Betancourt-Cravioto M, Cervantes-Powell P, Tapia-Conyer R, Ledlie S, Gandhi-Banga S. Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system. Human Vaccines & Immunotherapeutics 2022;18(1) View
  22. Fukushima A, Iessa N, Balakrishnan M, Pal S. Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience. BMC Medical Informatics and Decision Making 2022;22(1) View
  23. Psihogios A, Brianne Bota A, Mithani S, Greyson D, Zhu D, Fung S, Wilson S, Fell D, Top K, Bettinger J, Wilson K. A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study. Vaccine 2022;40(31):4065 View
  24. Nyambayo P, Gold M, Mehta U, Clarke S, Manyevere R, Chirinda L, Zifamba E, Nyamandi T. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial. Vaccine 2023;41(45):6700 View
  25. Assefa D, Tesefaye T, Bekele E, Geberemickeal G, Mebratu A, Ejigu A, Nigatu T, Zeleke E. Active surveillance of immunization adverse effects: a multicentre, open-label, three-arm randomized uncontrolled trial in Ethiopia. International Health 2024 View

Books/Policy Documents

  1. Paudyal V. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries. View
  2. Molia S, Bonnet P, Ratnadass A. Family Farming and the Worlds to Come. View
  3. Albrecht U, Pramann O. Re-Engineering Clinical Trials. View
  4. van der Spuy S. Pharmacovigilance. View
  5. Bousquet J, Sousa-Pinto B, Puggioni F, Anto A, Balli F, Casale T, Czarlewski W, Bedbrook A, Brussino L, Gaga M, Gemicioglu B, Klimek L, Kvedariene V, Louis R, Sastre J, Scichilone N, Valiulis A, Zervas E, Yorgancioglu A, Zuberbier T, Anto J, Canonica G, Fonseca J. Asthma in the 21st Century. View